Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$36.71 - $44.15 $10,462 - $12,582
-285 Reduced 1.2%
23,542 $979,000
Q1 2023

May 02, 2023

SELL
$36.81 - $48.12 $65,889 - $86,134
-1,790 Reduced 6.99%
23,827 $984,000
Q4 2022

Feb 10, 2023

SELL
$35.68 - $44.71 $378,493 - $474,283
-10,608 Reduced 29.28%
25,617 $1.06 Million
Q3 2022

Nov 09, 2022

BUY
$42.51 - $54.02 $35,368 - $44,944
832 Added 2.35%
36,225 $1.59 Million
Q2 2022

Aug 15, 2022

BUY
$46.84 - $59.75 $10,164 - $12,965
217 Added 0.62%
35,393 $1.74 Million
Q1 2022

Jun 30, 2022

SELL
$48.09 - $57.79 $81,368 - $97,780
-1,692 Reduced 4.59%
35,176 $1.99 Million
Q4 2021

Feb 15, 2022

BUY
$47.19 - $62.68 $8,258 - $10,969
175 Added 0.48%
36,868 $1.94 Million
Q3 2021

Oct 29, 2021

SELL
$56.91 - $67.81 $220,298 - $262,492
-3,871 Reduced 9.54%
36,693 $2.2 Million
Q2 2021

Aug 16, 2021

BUY
$64.02 - $71.72 $2.1 Million - $2.35 Million
32,800 Added 422.46%
40,564 $2.75 Million
Q1 2021

May 13, 2021

SELL
$53.26 - $68.08 $38,080 - $48,677
-715 Reduced 8.43%
7,764 $509,000
Q4 2020

Feb 12, 2021

BUY
$43.41 - $56.51 $3,429 - $4,464
79 Added 0.94%
8,479 $477,000
Q3 2020

Oct 30, 2020

SELL
$47.43 - $60.75 $13,090 - $16,767
-276 Reduced 3.18%
8,400 $408,000
Q2 2020

Aug 10, 2020

SELL
$43.51 - $66.59 $46,425 - $71,051
-1,067 Reduced 10.95%
8,676 $483,000
Q1 2020

May 13, 2020

SELL
$32.82 - $81.13 $11,454 - $28,314
-349 Reduced 3.46%
9,743 $494,000
Q4 2019

Feb 13, 2020

BUY
$60.96 - $77.7 $26,944 - $34,343
442 Added 4.58%
10,092 $781,000
Q3 2019

Nov 13, 2019

SELL
$55.78 - $68.08 $8,255 - $10,075
-148 Reduced 1.51%
9,650 $612,000
Q2 2019

Aug 14, 2019

BUY
$53.69 - $65.47 $82,682 - $100,823
1,540 Added 18.65%
9,798 $574,000
Q1 2019

May 15, 2019

BUY
$44.53 - $58.9 $8,594 - $11,367
193 Added 2.39%
8,258 $469,000
Q4 2018

Feb 15, 2019

BUY
$47.64 - $71.26 $216,380 - $323,662
4,542 Added 128.92%
8,065 $400,000
Q3 2018

Nov 14, 2018

SELL
$52.03 - $71.41 $252,917 - $347,124
-4,861 Reduced 57.98%
3,523 $250,000
Q2 2018

Jul 18, 2018

BUY
$48.15 - $56.68 $52,290 - $61,554
1,086 Added 14.88%
8,384 $437,000
Q1 2018

May 22, 2018

SELL
$46.03 - $61.28 $6,398 - $8,517
-139 Reduced 1.87%
7,298 $381,000
Q4 2017

Feb 13, 2018

BUY
$50.58 - $60.79 $23,367 - $28,084
462 Added 6.62%
7,437 $435,000
Q3 2017

Nov 09, 2017

BUY
$53.54 - $68.0 $373,441 - $474,300
6,975
6,975 $387,000

Others Institutions Holding NUVA

About NUVASIVE INC


  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.